|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 2/11/19 Entia Biosciences, Inc. 15-12G/A 2/11/19 1:13K Federal Filings, LLC/FA |
Document/Exhibit Description Pages Size
1: 15-12G/A Amendment to Certification of Termination of HTML 10K
Registration of a Class of Securities
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15-A
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER
SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION
OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 000-52864
Entia Biosciences, Inc.
(Exact name of registrant as specified in its charter)
13565 SW Tualatin-Sherwood Road, Suite 800, Sherwood, Oregon
(971) 228-0709
(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)
Common Stock
(Title of each class of securities covered by this form.)
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
| Rule 12g-4(a)(1) | ☐ | |
| Rule 12g-4(a)(2) | ☒ | |
| Rule 12h-3(b)(1)(i) | ☐ | |
| Rule 12h-3(b)(1)(ii) | ☒ | |
| Rule 15d-6 | ☐ | |
| Rule 15d-22(b) | ☐ |
Approximate number of holders of record as of the certification or notice date: 313
Pursuant to the requirements of the Securities Exchange Act of 1934, Entia Biosciences, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
Date: February 8, 2019 By: /s/ Timothy A. Timmins
Timothy A. Timmins
President and Chief Executive Officer
Instruction: This form is required by Rules 12g-4, 12h-3, 15d-6 and 15d-22 of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counselor by any other duly authorized person. The name and title of the person signing the form shall be typed or printed under the signature.
SEC 2069 (08-11)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.